Stedman T, Chew P, Truran P, Lim C B, Balasubramanian S P
Sheffield Teaching Hospitals NHS Foundation Trust , UK.
Ann R Coll Surg Engl. 2018 Feb;100(2):135-139. doi: 10.1308/rcsann.2017.0194. Epub 2017 Nov 28.
Introduction The management of post-thyroidectomy hypocalcaemia should facilitate early discharge, and reduce risks of hypocalcaemia, readmission and treatment related hypercalcaemia. This paper describes the implementation, evaluation and revision a protocol for the optimal management of this condition. Methods Day 1 parathyroid hormone (PTH) measurements in addition to calcium measurements were commenced following review of the unit's outcomes and literature on post-thyroidectomy hypocalcaemia. Outcomes from a three-year cohort of patients undergoing thyroid surgery helped amend this protocol (revision 1) to reduce biochemical tests, stipulate the need, nature and dose of vitamin D/calcium supplements, and encourage early discharge. This was further validated over seven months to assess compliance, episodes of hyper and/or hypocalcaemia after discharge, readmissions and need for treatment changes. Further revisions were made (revision 2) and implemented. Results The temporary and long-term postoperative hypocalcaemia rates were 29.1% and 3.2% respectively. Repeat calcium measurements on the first day altered management in only 1.4% of cases. The revised protocol was adhered to in 90% of cases. One patient had hypocalcaemia (due to non-compliance) and one had hypercalcaemia. Revision 2 involved reducing the dose of calcium. Conclusions This is a good example of a unit protocol for post-thyroidectomy hypocalcaemia being developed and modified on the basis of the literature and local experience. Day 1 PTH and calcium levels determine the need for treatment and frequency of follow-up visits, facilitate early discharge, reduce risk of over and/or undertreatment, and are good indicators of permanent hypocalcaemia.
引言 甲状腺切除术后低钙血症的管理应有助于患者早日出院,并降低低钙血症、再入院及治疗相关高钙血症的风险。本文描述了针对这一病症的最佳管理方案的实施、评估及修订情况。方法 在回顾本单位的治疗结果及有关甲状腺切除术后低钙血症的文献后,除了测量血钙水平外,开始在术后第1天测量甲状旁腺激素(PTH)。对一组接受甲状腺手术的患者进行了为期三年的跟踪,其结果有助于修订该方案(修订版1),以减少生化检查项目,明确维生素D/钙剂补充的必要性、性质及剂量,并鼓励早日出院。在七个月的时间里对该方案作了进一步验证,以评估其依从性、出院后高钙血症和/或低钙血症的发作情况、再入院情况以及治疗调整的必要性。之后又进行了进一步修订(修订版2)并予以实施。结果 术后暂时性和永久性低钙血症的发生率分别为29.1%和3.2%。术后第1天重复测量血钙水平仅在1.4%的病例中改变了治疗方案。90%的病例遵循了修订后的方案。1例患者出现低钙血症(因未遵医嘱),1例出现高钙血症。修订版2涉及减少钙剂剂量。结论 这是一个很好的范例,说明一个关于甲状腺切除术后低钙血症的单位方案是如何根据文献和当地经验制定及修改的。术后第1天的PTH和血钙水平决定了治疗的必要性及随访频率,有助于早日出院,降低治疗过度和/或不足的风险,并且是永久性低钙血症的良好指标。